Polysulfates block SARS-CoV-2 uptake via electrostatic interactions

Nie, Chuanxiong; Pouyan, Paria; Lauster, Daniel; Trimpert, Jakob; Kerkhoff, Yannic; Szekeres, Gergo Peter; Wallert, Matthias; Block, Stephan; Sahoo, Anil Kumar; Dernedde, Jens; Pagel, Kevin; Kaufer, Benedikt B.; Roland,; Netz, R.; Ballauff, Matthias; Haag, Rainer

doi:10.1002/anie.202102717

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

このアイテムの新しいバージョンが利用可能です:
https://pure.mpg.de/pubman/item/item_3289093_7

詳細要約

公開

学術論文

Polysulfates block SARS-CoV-2 uptake via electrostatic interactions

MPS-Authors

/persons/resource/persons257432

Sahoo, Anil Kumar
Richard Weinkamer, Biomaterialien, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

Preprint.pdf
(プレプリント), 658KB

付随資料 (公開)

There is no public supplementary material available

引用

Nie, C., Pouyan, P., Lauster, D., Trimpert, J., Kerkhoff, Y., Szekeres, G. P., Wallert, M., Block, S., Sahoo, A. K., Dernedde, J., Pagel, K., Kaufer, B. B., Roland, Netz, R., Ballauff, M., & Haag, R. (2021). Polysulfates block SARS-CoV-2 uptake via electrostatic interactions. Angewandte Chemie International Edition. doi:10.1002/anie.202102717.

引用: https://hdl.handle.net/21.11116/0000-0008-1CB4-E

要旨

Here we report that negatively charged polysulfates can bind to the spike protein of SARS-CoV-2 via electrostatic interactions. Using a plaque reduction assay, we compare inhibition of SARS-CoV-2 by heparin, pentosan sulfate, linear polyglycerol sulfate (LPGS) and hyperbranched polyglycerol sulfate (HPGS). Highly sulfated LPGS is the optimal inhibitor, with a half-maximal inhibitory concentration (IC₅₀) of 67 μg/mL (approx.1.6 μM). This synthetic polysulfates exhibit more than 60-fold higher virus inhibitory activity than heparin (IC₅₀: 4084μg/mL), along with much lower anticoagulant activity. Furthermore, in molecular dynamics simulations, we verified that LPGS can bind stronger to the spike protein than heparin, and that LPGS can interact even morewith the spike protein of the new N501Y and E484K variants. Our study demonstrates that the entry of SARS-CoV-2 into host cells can be blocked via electrostatic interaction, therefore LPGS can serve as a blueprint for the design of novel viral inhibitors of SARS-CoV-2.